SPINNING SPIROS
Report
- Report Number
- 2025816-2016-00294
- Event Type
- Malfunction
- Date Received
- January 10, 2017
- Date of Event
- December 14, 2016
- Report Date
- January 10, 2017
- Manufacturer
- ICU MEDICAL, INC.
- Product Code
- FPA
- PMA / PMN Number
- K082806
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- NURSE
Narratives
SUSPECT LOT REVIEW: A REVIEW OF THE MFG. LOT DATABASE FOR SUSPECT LOT# 67-326-Y1 (MFG. DATE 08/2016) SHOWS (B)(4) UNITS WERE MFD., TESTED, INSPECTED, AND RELEASED CITING NO EXCEPTION DOCUMENTS. A REVIEW OF THE MFG. LOT DATABASE FOR SUSPECT LOT# 61-522-SJ (MFG. DATE 04/2016) SHOWS (B)(4) UNITS WERE MFD., TESTED, INSPECTED, AND RELEASED CITED NO EXCEPTION DOCUMENTS. VISUAL RECEIPT ANALYSIS: 12/29/2016 - RECEIVED THE FOLLOWING: TWO USED 20130-01, SPINNING SPIROS CLOSED MALE LUER, RED CAP; REPORTED LOT# 66-747-SL ONE USED MICROCLAVE CONNECTOR LOT# UNKNOWN, ONE USED TUBING EXTENSION, ONE USED BD 30 ML SYRINGE. FUNCTIONAL TESTING: THE RESIDUAL TORQUE OF THE SPIN FEATURE OF THE STAND ALONE SPIROS WAS MEASURED AT 0.03 IN-LBS. FINAL ANALYSIS SUMMARY: THE REPORT OF 20130-01 DISCONNECT WAS UNABLE TO BE CONFIRMED. WHEN A LARGE SYRINGE IS CONNECTED TO A SPIROS ASSEMBLY THIS CREATES A LONG LEVER AND CARE NEEDS TO BE TAKEN TO SUPPORT THE SPIROS AND NOT APPLY BENDING FORCES DURING USE. FAILURE TO DO SO CAN RESULT IN PREMATURE DISCONNECT. ICU MEDICAL WILL CONTINUE TO MONITOR AND TREND.
COMPLAINT REC'D REGARDING ONE (1) 20130-01, SPINNING SPIROS CLOSED MALE LUER, RED CAP; LOT# UNKNOWN. THE REPORT STATES, SPINNING SPIROS COMING DISCONNECTED FROM THE SYRINGE DURING THE PATIENT INFUSION. RESULTING IN CHEMO SPILL EXPOSING THE CHILD, FAMILY AND NURSING STAFF. THERE WAS AN UNSPECIFIED AMOUNT OF CHEMO EXPOSURE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 19046 | SPINNING SPIROS | SPINNING SPIROS | FPA | ICU MEDICAL, INC. | 20130-01 | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 15 YR |